SiMoA Quanterix, WuXi AppTec to Open Joint Lab in Shanghai The lab will provide researchers in the Asia-Pacific region with access to Quanterix's Simoa technology and biomarker testing, development, and validation services. Inventor of Quanterix Tech Exploring Point-of-Care Simoa Device for Tuberculosis Detection Premium In a study published this week, researchers presented a Simoa-based assay for tuberculosis that could ultimately be packaged as a point-of-care test. Quanterix Raises $49.7 in Stock Offering The company sold 2.2 million shares at an average price of $22.73 per share under a $50 million at-the-market equity facility it filed in March 2019. Quanterix Q1 Revenues Up 64 Percent The company posted Q1 revenues of $12.3 million, up from $7.5 million in Q1 2018 and above the consensus Wall Street estimate of $10.2 million. Quanterix, Partners Develop PCR-Free miRNA Detection Method for Liver Toxicity Testing Premium They demonstrated the applicability of the Simoa platform for nucleic acid detection, and miRNA detection in particular, as Quanterix prepares to launch a new system. Aug 7, 2015 New Study Describes Development of Simoa Assays for C. Diff Toxin Detection Premium Feb 20, 2015 Researchers Develop Simoa-based Assay for Dengue Fever Host Immune Response Mar 21, 2014 JAMA Neurology Study Uses Quanterix's Simoa Platform to Assess Hockey-related Brain Injury Premium Jan 23, 2014 Quanterix, Banyan Biomarkers among Winners of Research Awards for GE, NFL 'Head Health Challenge' Sep 3, 2013 Swedish Researchers Adopt Quanterix Arrays to Identify Concussion Biomarkers in Hockey Players Premium Aug 9, 2013 Quanterix Launches RUO Simoa Platform with 18 Initial Assays and Homebrew Kit Premium Aug 2, 2013 New Products: Quanterix Launches Simoa Instrument and More Premium Nov 27, 2012 BioMerieux Invests $15M in Quanterix, Will Use SiMoA to Support PSA and Infectious Disease Assays Premium Jul 24, 2012 Quanterix Building Commercial Team Ahead of Planned 2013 Launch for Simoa Platform Premium Feb 10, 2012 Forsyth Wins Gates Foundation Grant for TB Biomarker Work on Quanterix's SiMoA System Premium Jan 10, 2012 In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications Premium Jan 6, 2012 With Backing from In-Q-Tel, Quanterix Continues Move into Pathogen Detection, Defense Applications Premium Oct 21, 2011 Quanterix's AccuPSA Test Predicts Five-Year Recurrence-Free Survival in Prostate Cancer Study Premium Aug 16, 2011 Quanterix, Stratec Partner on Tool for Life Sciences, IVD Jun 3, 2011 Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade Premium Feb 25, 2011 Shifting Focus From Dx Development, Quanterix Aims to Launch Commercial SiMoA Instrument in 2013 Premium Nov 2, 2010 Quanterix Wins $733K QTDP Grant to Develop Array-Based Prostate Cancer Test Premium Jun 11, 2010 Study Shows Quanterix's Single Molecule Array Assay Measures PSA at Previously Undetectable Levels Premium Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.